Sheila Sharifi

Ms. Sheila Sharifi


Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 February 2025 in Archives of Dermatological Research
Verified
Journal Article
Closed access
SSSheila Sharifi
Sheila Sharifi
OKOlivia Katamanin
Olivia Katamanin
MJMohammad Jafferany
Mohammad Jafferany


16 October 2024 in Archives of Dermatological Research
Verified
Journal Article
Closed access
PDF file
SSSheila Sharifi
Sheila Sharifi
RSRyan Scheinkman
Ryan Scheinkman
LTLea Tordjman
Lea Tordjman
APAnika Pulumati
Anika Pulumati
KNKeyvan Nouri
Keyvan Nouri

8 April 2025 in Lasers in Medical Science
Verified
Journal Article
Closed access
SSSheila Sharifi
Sheila Sharifi
ASAndrew Spires
Andrew Spires
LDLauren Dender
Lauren Dender
KNKeyvan Nouri
Keyvan Nouri

28 April 2025 in Journal of Cosmetic Dermatology
Verified
Journal Article
Open access
SSSheila Sharifi
Sheila Sharifi
MJMohammad Jafferany
Mohammad Jafferany

18 September 2025 in Pediatric Dermatology
Verified
Journal Article
Open access
SSSheila Sharifi
Sheila Sharifi
MEMariah Estill
Mariah Estill
LTLea Tordjman
Lea Tordjman
SMSarah H. Millan
Sarah H. Millan
JOJessica X. Ouyang
Jessica X. Ouyang
Trichotillomania (TTM) is a condition characterized by recurrent hair pulling, often resulting in hair loss and functional impairment. The disorder remains underreported in the pediatric population, despite high rates of psychiatric comorbidities. Moreover, diagnosing and treating TTM among children remains challenging due to a lack of standardized guidelines. Hence, this systematic review aims to evaluate the current treatment approaches for pediatric TTM. A comprehensive search was conducted of five databases, using the search concepts of trichotillomania, pediatric populations, and treatments/interventions. Studies were included if they (1) directly addressed the topic, (2) were of an appropriate study type (e.g., clinical trials, case–control studies, cohort studies, cross‐sectional studies, or interview studies), (3) were published within the past 10 years, and (4) appeared in peer‐reviewed journals published in English. Ultimately, 10 studies met our inclusion criteria, from which data were extracted and synthesized following formal quality assessment. Our results indicate that behavioral interventions, particularly habit reversal training, consistently demonstrated the greatest therapeutic benefit. Pharmacological treatments, including selective serotonin reuptake inhibitors, have been explored in various case series. Although some individuals have shown improvement, overall evidence remains insufficient to support pharmacotherapy as first‐line. Alternative therapies, such as N‐acetylcysteine, have also been studied, though findings are variable and require further investigation in pediatric cohorts. Our review underscores the importance of early behavioral intervention and the need for larger, controlled studies to inform standardized treatment protocols. Given the functional and psychosocial burden of TTM in youth, comprehensive management strategies are essential.